Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Pharmazie ; 74(10): 620-624, 2019 10 01.
Artículo en Inglés | MEDLINE | ID: mdl-31685089

RESUMEN

Rikkunshito has been shown to improve upper gastrointestinal symptoms and anorexia. The aim of this study was to evaluate whether rikkunshito improves chemotherapy-induced nausea in thoracic cancer patients receiving carboplatin (CBDCA)-based chemotherapy. A retrospective before-and-after comparison study was conducted in patients with thoracic cancer receiving the first cycle of CBDCA-based chemotherapy. Among 61 eligible patients, 34 received standard antiemetic therapy with a combination of 5-hydroxytryptamine-3 receptor antagonist and dexamethasone from September 2012 and June 2013 (standard group), while the other 27 received the standard antiemetic therapy plus oral rikkunshito from July 2013 and December 2014 (rikkunshito group). The rates of no nausea showed no significant difference between the standard and rikkunshito group (Overall phase: 64.7 % for standard group vs 74.1 % for rikkunshito group, p = 0.579). Subgroup analysis indicated that, in female patients, the rates of no nausea in rikkunshito groups was significantly higher than in standard group (overall phase: 44.4 % vs 100 %, p = 0.034). Rikkunshito did not demonstrate an additional prophylactic effect on standard antiemetic therapy for nausea in patients with thoracic cancer receiving CBDCA-based chemotherapy, but showed a prophylactic effect of nausea in female patients.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Medicamentos Herbarios Chinos/uso terapéutico , Náusea/prevención & control , Anciano , Anciano de 80 o más Años , Antieméticos/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carboplatino/administración & dosificación , Carboplatino/efectos adversos , Dexametasona/uso terapéutico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Náusea/inducido químicamente , Náusea/tratamiento farmacológico , Estudios Retrospectivos
2.
Data Brief ; 52: 109856, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-38146293

RESUMEN

This data article provides temporally and spatially high-resolution datasets of the indoor velocity fields for cross-ventilation models of two-layered simplified buildings separated by a second floor at the middle height with an opening using wind-tunnel experiments. The datasets are based on the research article entitled "Quantifying natural cross-ventilation flow of a two-layered model used for terraced houses in tropical zones by particle image velocimetry" by Ali et al. [1]. Two cases are considered based on the positions of the inlet and outlet openings on each floor. The measurements were conducted using hot-wire anemometry (HWA) with 10,000 Hz and particle image velocimetry (PIV) with 1000 Hz for a sufficiently long period to determine reliable statistics of the mean, variances, and covariances. In addition, the article provides the instantaneous datasets of two velocity components determined by PIV for the cross-ventilation models. The datasets can be used for both computational fluid dynamics (CFD) validation and further investigation of turbulent flow nature of the multi-layer cross ventilation flow.

3.
Oncogene ; 19(53): 6138-43, 2000 Dec 11.
Artículo en Inglés | MEDLINE | ID: mdl-11156527

RESUMEN

Overexpression of the HER2/neu oncogene is observed in approximately 30% of human breast carcinoma specimens. HER2/neu overexpression is a negative prognostic factor in breast cancer patients. Cancer cells that overexpress HER2/neu may also be less sensitive to chemotherapy. In order to further define mechanisms by which HER2/neu overexpression drives neoplastic cell growth and chemoresistance, antisense oligonucleotides (ODNs) have been utilized to selectively down-regulate HER2/neu expression in human breast cancer cells. Such antisense ODNs suppress HER2/neu mRNA and protein levels in a dose-dependent, sequence-specific manner. Down-regulation of HER2/neu expression in HER2/neu overexpressing breast cancer cells inhibits cell cycle progression in G0/G1 and results in apoptotic cell death. In tissue culture studies, combined treatment of HER2/ neu overexpressing breast cancer cells with HER2/neu antisense ODNs and conventional chemotherapeutic agents results in synergistic inhibition of cancer cell growth and activation of apoptotic cell death mechanisms. These studies have been extended to demonstrate synergistic antitumor effects following systemic treatment with antisense ODNs plus doxorubicin in nude mice bearing human breast carcinoma xenografts. Collectively these findings demonstrate that HER2/neu overexpression stimulates anti-apoptotic cell survival mechanisms and suggest that HER2/neu antisense ODNs may be of use in cancer therapeutics.


Asunto(s)
Antineoplásicos/farmacología , Neoplasias de la Mama/terapia , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Oligonucleótidos Antisentido/farmacología , Receptor ErbB-2/genética , Animales , Neoplasias de la Mama/genética , División Celular , Humanos , Células Tumorales Cultivadas
4.
Surgery ; 126(2): 413-21, 1999 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10455915

RESUMEN

BACKGROUND: The HER2/neu oncogene is overexpressed in a substantial fraction of human tumors. HER2/neu overexpressing tumors may be intrinsically resistant to chemotherapy. The present study examined the ability of antisense-mediated downregulation of HER2/neu expression to enhance the antitumor effects of conventional chemotherapeutic agents against human tumor cells that overexpress HER2/neu. METHODS: The effects of HER2/neu antisense oligodeoxynucleotides (ODNs) on the growth inhibitory and proapoptotic activity of several distinct chemotherapeutic agents were examined in vitro. In vivo effects of HER2/neu antisense ODNs in combination with doxorubicin hydrochloride were assessed by examining the growth of human tumor xenografts implanted into nude mice. RESULTS: The proliferation of tumor cell lines that overexpress HER2/neu was inhibited by antisense ODNs in combination with conventional chemotherapeutic agents in an additive or synergistic fashion. Such combination therapy also demonstrated synergistic activation of apoptosis. HER2/neu antisense ODNs in combination with doxorubicin hydrochloride demonstrated synergistic antitumor effects in vivo as well. CONCLUSIONS: Downregulation of HER2/neu expression can enhance the sensitivity of human cancer cells, which overexpress HER2/neu to the cytotoxic effects of chemotherapy. Antisense ODNs targeting the HER2/neu gene may play a role in cancer therapy.


Asunto(s)
Antineoplásicos/farmacología , Oligonucleótidos Antisentido/farmacología , Receptor ErbB-2/antagonistas & inhibidores , Animales , Apoptosis/efectos de los fármacos , Regulación hacia Abajo , Doxorrubicina/farmacología , Sinergismo Farmacológico , Femenino , Humanos , Ratones , Ratones Desnudos , Tamoxifeno/farmacología , Células Tumorales Cultivadas
5.
Spectrochim Acta A Mol Biomol Spectrosc ; 56A(11): 2141-8, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11058059

RESUMEN

Ab initio molecular orbital calculations were carried out to investigate the inter-radical interaction of the paired p-phenylenediamine radical cations in the singlet state. After initial optimization of the dimer in the parallel sandwich (D2h) and parallel displaced (Cs) configurations at the B3LYP/6-31G* theoretical level, the MP2/6-31G* and B3LYP/6-31G* single energies of the dimer were calculated as a function of the inter-radical distance R. The depths of the potential minima near R = 3.2 A were estimated to be in the order of the hydrogen bonding energy, assuming that the electrostatic contribution between the cations is canceled out by the attractive contributions due to the counter anions on the aspect of a simple electrostatic model. This can be related to the indications of the cation dimer formation in solution in the presence of counter anions at a low temperature reported previously in the literature by resonance Raman and electronic absorption spectra. The inter-radical (Raman active) frequencies of the dimer were calculated, one of which corresponds to the reported value at 161 cm(-1) observed in the resonance Raman spectrum in ethanol at 200 K by Yokoyama and Maeda (Chem. Phys. Lett. 48 (1977) 59).


Asunto(s)
Cationes/química , Fenilendiaminas/química , Espectrometría Raman , Dimerización , Estructura Molecular
6.
Yakugaku Zasshi ; 112(3): 193-8, 1992 Mar.
Artículo en Japonés | MEDLINE | ID: mdl-1608043

RESUMEN

The percutaneous absorption of drug from the alpha-olefin oligomer (alpha-OL) gel base prepared by using palmitate of dextrin (Rheopearl KL) as a gelling agent was investigated by using the abdominal skin of rats in vivo. The 20, 30, 40 and 50 alpha-OLs with average molecular weights of 288, 380, 440 and 535, respectively were used in this study. The flurbiprofen (FP) was selected as a model drug. The percutaneous absorption of FP from the alpha-OL gel base was observed to be influenced by the molecular weight of alpha-OL. The percutaneous absorption profiles of FP from 40 and 50 alpha-OLs gel bases were almost the same. On the other hand, the absorption of FP from 30 alpha-OL gel base was significantly higher than those of 40 and 50 alpha-OLs gel bases. Furthermore, the percutaneous absorption of FP from 20 alpha-OL gel base was observed to be the highest in the test gel bases. In order to establish the reason for the differences in the percutaneous absorption of FP from 20, 30, 40 and 50 alpha-OLs gel bases, the apparent partition ratios of FP between water and four different alpha-OLs were determined as a parameter of the affinity of FP for the vehicle. Consequently, it has become apparent that the partition ratio exerts an influence on the percutaneous absorption of FP from the alpha-OL gel bases.


Asunto(s)
Alquenos , Bases Oleosas , Absorción Cutánea , Animales , Flurbiprofeno/sangre , Flurbiprofeno/farmacocinética , Geles , Masculino , Peso Molecular , Ratas , Ratas Endogámicas
7.
Kyobu Geka ; 48(3): 239-41, 1995 Mar.
Artículo en Japonés | MEDLINE | ID: mdl-7897907

RESUMEN

A 64-year-old female was referred to our hospital for further examination of a coin lesion, 8 mm in diameter, superimposed on the right ninth posterior rib. CT revealed a nodule, close to the minor fissure, with spiculation, which seemed to be connected with the pulmonary vein. Since the bronchofiberscopic examination revealed no histological diagnosis, the exploratory thoracotomy was performed. The nodule was found to be a 10 x 7 x 5 mm black mass located subpleural at the minor fissure. Histologically, it was recognized as a lymph node with anthracosis and silicotic nodules.


Asunto(s)
Neoplasias Pulmonares/diagnóstico por imagen , Pulmón/patología , Ganglios Linfáticos/diagnóstico por imagen , Nódulo Pulmonar Solitario/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Diagnóstico Diferencial , Femenino , Humanos , Persona de Mediana Edad
8.
Gan To Kagaku Ryoho ; 15(9): 2713-7, 1988 Sep.
Artículo en Japonés | MEDLINE | ID: mdl-3415269

RESUMEN

Although CDDP has been widely used for cancer chemotherapy in recent years, the problem is that it causes a renal dysfunction as a side effect. As briefly reported here, we have currently used this drug for the treatment of stomach esophageal cancers as a part of multidepartmental therapy, and obtained a finding on the therapeutic usefulness, particularly for monitoring the renal function before and after administration. The subjects were 6 patients with stomach and 11 with esophageal cancer given CDDP at the dose of 50 mg 2 courses, in principle, a single course per week. Blood transfusion was carried out in an amount of 1,000 ml before administration, 2,500 ml on the day of treatment and 1,000 ml for 3 days after administration. When the effects of CDDP on urinary BUN, Na, K, Cl, Mg, NAG, beta 2 microglobulin, Ccr and FENa levels were measured for the determination of renal functions before and after administration, NAG and beta 2 microglobulin levels were conceivably found to be useful indices.


Asunto(s)
Cisplatino/administración & dosificación , Neoplasias Esofágicas/tratamiento farmacológico , Riñón/fisiopatología , Neoplasias Gástricas/tratamiento farmacológico , Adulto , Anciano , Nitrógeno de la Urea Sanguínea , Creatinina/sangre , Esquema de Medicación , Neoplasias Esofágicas/fisiopatología , Femenino , Humanos , Pruebas de Función Renal , Masculino , Persona de Mediana Edad , Neoplasias Gástricas/fisiopatología
10.
Phys Rev Lett ; 57(6): 711-714, 1986 Aug 11.
Artículo en Inglés | MEDLINE | ID: mdl-10034138
15.
Biol Blood Marrow Transplant ; 2(3): 118-25, 1996 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-9199754

RESUMEN

Donor CD4+ and CD8+ T cells mediate graft-vs.-leukemia (GVL) responses in the allogeneic bone marrow transplantation (alloBMT) setting. To evaluate the role of functional T cell subsets in the mediation of GVL, alloreactive donor CD4+ (Th1/Th2) and CD8+ (Tc1/Tc2) T cells of defined cytokine phenotype were generated by in vitro culture. A leukemia/transplantation model (B6 into B6C3F1; 1050 cGy host irradiation) was established using the bcr/abl-transfected myeloid leukemia line, 32Dp210 (P210; H-2k). Leukemia control mice (1X10(4) P210 cells per recipient) died at day 12.0 post-BMT. Recipients of the CD4+, Th1-type or CD8+, Tc1-type populations were conferred a survival advantage (death at 20.7 and 23.5 days post-BMT, respectively). In contrast, the CD4+, Th2-type population did not mediate GVL (death at 12.3 days). Furthermore, cell mixing experiments demonstrated that the Th2 subset abrogated both Th1- and Tc1-mediated GVL. The CD8+, Tc2 population, which secreted type II cytokines and lysed the P210 leukemia target in vitro, mediated GVL in some experiments; interestingly, the magnitude of Tc2-mediated GVL was inversely related to the level of interleukin-10 (IL-10) secreted in vitro by the Tc2 population. These studies therefore indicate that alloreactive T cells of type I phenotype maximally generate GVL, and that type I/type II interactions are an important consideration for allogeneic transplantation in the setting of leukemic hosts.


Asunto(s)
Enfermedad Injerto contra Huésped/inmunología , Linfocitos T/inmunología , Trasplante Homólogo/inmunología , Animales , Trasplante de Médula Ósea/inmunología , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Células Cultivadas/inmunología , Citocinas/metabolismo , Citotoxicidad Inmunológica , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Citometría de Flujo , Humanos , Interleucina-10/biosíntesis , Interleucina-10/inmunología , Isoantígenos/inmunología , Leucemia Experimental/inmunología , Leucemia Experimental/metabolismo , Leucemia Experimental/terapia , Ratones , Ratones Endogámicos C57BL , Conejos , Bazo/citología , Bazo/inmunología , Subgrupos de Linfocitos T/inmunología , Células TH1/inmunología , Células Th2/inmunología
16.
J Comput Assist Tomogr ; 15(2): 287-90, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-2002109

RESUMEN

For evaluation of thyroidal iodine kinetics and thyroid nodules, we carried out quantitative in vivo measurement of thyroid iodine concentration by CT. Neuron activation analysis of iodine content was conducted on 48 thyroid fragments without calcification operatively obtained from 18 patients who had undergone CT of the thyroid without contrast enhancement. The CT attenuation values were obtained from the regions of interest in the CT image that corresponded to the analyzed fragment. When iodine concentration in the thyroid tissue was greater than 0.02 mg/g, the CT values correlated linearly with the iodine concentrations in thyroid nodules, thyroids with diffuse thyroid disease, and normal thyroids. The relationship is represented by the following formula: iodine concentration (mg/g) = (CT value-65)/104. The relationship between iodine concentration and CT value in diffuse thyroid disease, thyroid nodules, and normal thyroids was not significantly different.


Asunto(s)
Yodo/metabolismo , Glándula Tiroides/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Humanos , Valores de Referencia , Enfermedades de la Tiroides/diagnóstico por imagen , Glándula Tiroides/metabolismo
17.
Jpn Hosp ; (20): 11-20, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12063837

RESUMEN

The Japan Society for Quality in Health Care (JSQua) created "Standards for the Evaluation of Hospital Infection Control Policies and Procedures, the First Version" in 1998 and carried out third-party surveys. Through the experience of those surveys, we revised the standards and created a second version in 1999. The surveyors felt that in using the second version of the standards it would be easier to evaluate the quality of hospital care and that these standards would be more widely applied.


Asunto(s)
Infección Hospitalaria/prevención & control , Guías como Asunto , Hospitales/normas , Control de Infecciones/normas , Política Organizacional , Encuestas de Atención de la Salud , Humanos , Japón , Sociedades
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA